Vowst
My Prescription
Payment
Select pharmacy
$20,317.45
Print or send this coupon to your phone
AlbertsonsPowered byAbout Vowst
Drug Details
This product is designed to prevent the recurrence of a specific intestinal infection known as Clostridium difficile (CDI) after antibiotic treatment. It is derived from the stool of carefully screened human donors and functions by introducing healthy bacteria into the intestines. It is important to note that this product is not used for the treatment of CDI itself.
Price history for Vowst
12, 1nan
Average retail price for Vowst
Average SaveHealth price for Vowst
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Vowst dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 1nan | 12 Capsules | $20,317.45 | $1,693.12 |
Vowst FAQs
Vowst is not a traditional fecal transplant. It is an oral microbiome therapeutic that contains live bacteria derived from human stool, designed to prevent the recurrence of Clostridioides difficile infection.
Vowst is prescribed for the prevention of recurrence of Clostridioides difficile infection (CDI) in patients who are 18 years of age and older, following antibacterial treatment for recurrent CDI.
Yes, Vowst is considered a specialty drug. Specialty drugs are typically used to treat complex or rare conditions and often require special handling, administration, or monitoring.
VOWST and FMT (Fecal Microbiota Transplantation) are related but not the same. VOWST is an oral microbiome therapeutic that contains live bacteria and is used to prevent the recurrence of Clostridioides difficile infection. It is derived from human fecal matter but is processed and encapsulated for oral administration. FMT, on the other hand, involves the direct transfer of stool from a healthy donor to the gastrointestinal tract of a patient, typically via colonoscopy, enema, or a nasogastric tube. Both aim to restore healthy gut flora but differ in their method of administration and formulation.
Yes, Vowst is an oral microbiota-based treatment that is used to prevent the recurrence of Clostridioides difficile (C. diff) infection in adults following antibiotic treatment. It is designed to restore the gut microbiome balance and reduce the risk of further infections.